Phase I/II Trial of Torisel and Liposomal Doxorubicin in Patients With Advanced Soft Tissue and Bone Sarcomas.
Phase of Trial: Phase I/II
Latest Information Update: 24 May 2018
At a glance
- Drugs Temsirolimus (Primary) ; Doxorubicin liposomal
- Indications Osteosarcoma; Soft tissue sarcoma
- Focus Adverse reactions
- 02 Jun 2015 Results of the phase II portion in 18 patients presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
- 01 Sep 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 24 Sep 2009 Actual initiation date (Sep 2009) added as reported by ClinicalTrials.gov.